LISA ETTIENNE: Open Payments
NPI 1568036630 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,118 in 57 payments from 14 companies in 2025. Trend: 2023 $1,817 · 2024 $1,416 · 2025 $1,118
Food & beverage: $1,118
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 27 | $259 |
| Collegium Pharmaceutical, Inc. | 10 | $173 |
| ABBVIE INC. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Tris Pharma Inc | 4 | $69 |
| Seqirus USA Inc | 4 | $64 |
| PFIZER INC. | 2 | $51 |
| Cranial Technologies, Inc | 2 | $36 |
| SpringWorks Therapeutics, Inc. | 1 | $23 |
Products named: Qelbree, Jornay PM, VRAYLAR, PENMENVY, AIRSUPRA, Dyanavel XR, Flucelvax, TRUMENBA.
Industry payments across WI — which companies pay providers there.
